Market Research Future
Cell Surface Markers Market is expected to expand at 8.4% CAGR during the forecast period 2019 to 2023
Cell Surface Markers Market – Scenario The global cell surface markers market is anticipated to hold a market value of USD 498 million in the year 2017 and is expected to grow at a CAGR of 8.4% during the forecast period. Cell surface markers or cell surface antigen work as monograms for identification and classification of cells. The proteins that are expressed on the cell surfaces often conveniently work as markers for specific types of cells. Increasing expenditure in the advancement of healthcare technology, advancement in technology, acquisitions by companies and outlook for reduction of costs associated with disease diagnosis are expected to drive the growth in the market over the forecast period. For instance, in April 2014, Beckman Coulter, acquired Xitogen Technologies, a cytometer manufacturer. This acquisition helped Beckman Coulter to broaden its product offerings and enabled business expansion in Asia. However, complex products and expensive instruments & reagents can restrain the market growth over the assessment period.
Request Free Sample https://www.marketresearchfuture.com/sample_request/7410
Copy
at
Key Players Some of the prominent players in the global cell surface markers market are Bio-Rad Laboratories, Inc., Abbott, Siemens Healthcare Private Limited, Beckman Coulter, Inc. , F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION, Thermo Fisher Scientific, BD, Abcam plc., QIAGEN, Danaher, GenScript, Merk KGaA, BioLegend, Inc., Cell Signaling Technology, Inc., Bio-Techne and Others. Segments: The global cell surface markers market has been segmented into product, source, cell type and application. The market, on the basis of product, has been segmented into antibody and PCR array. The global market, on the basis of source, has been segmented into mice, rat and others.